Navigantis Inc. has achieved a significant milestone by performing its initial clinical procedures with the Vasco surgical robot, aimed at treating various neurovascular disorders. This advancement reflects the company’s ongoing efforts to integrate robotic technology into critical surgical interventions, potentially enhancing precision and expanding access to specialized care in diverse medical settings.
Earlier reports highlighted Navigantis’ progress in robotic liver tumor embolization during 2022 trials. The latest developments with Vasco indicate a broader application of their technology in neurovascular procedures, showcasing their commitment to advancing medical robotics beyond initial use cases.
What are the latest clinical achievements?
Navigantis recently conducted successful interventional cases, including diagnostic cerebral angiograms, brain tumor embolizations, and mechanical thrombectomies for ischemic stroke patients. These procedures demonstrate the Vasco platform’s capability to handle complex and time-sensitive neurovascular tasks effectively.
How does the Vasco platform enhance procedures?
The Vasco robotic system is designed to reduce radiation exposure by minimizing the need for fluoroscopy during endovascular procedures. This not only enhances the safety of both patients and medical staff but also improves procedural accuracy and efficiency.
“The Vasco robotic platform has the potential to redefine how we approach the most complex and time-sensitive neurovascular procedures, ultimately improving both patient outcomes and procedural efficiencies,”
stated CEO Mor Dayan.
What are Navigantis’ future plans?
Following the successful clinical trials, Navigantis plans to advance Vasco through further testing and development phases. The company recently secured $12 million in Series A funding to support ongoing research and expand the robot’s application in neurovascular surgeries. This funding will facilitate the transition of Vasco into broader clinical trials and eventual commercial use.
As Navigantis continues to innovate within the medical robotics field, the integration of Vasco into more complex surgeries could significantly impact the standard of care for neurovascular diseases. By addressing current limitations in specialist availability and procedural access, the Vasco platform may contribute to timely and effective treatments for patients in need.
Navigantis’ progress with the Vasco robot underscores the potential for robotic assistance in highly specialized medical procedures. Continued advancements and successful trials will be crucial in determining the long-term viability and adoption of such technologies in healthcare systems worldwide.
